Evaluation of Guided Tissue Regeneration With Autogenous Bone Chips and CGF During Implant Placement
Condition(s) studied
Investigational drug(s) / intervention(s)
concentrated growth factor (CGF) Membrane: This is a third-generation autologous blood concentrate prepared using a dedicated centrifuge system. The process creates a fibrin-rich organic matrix from the patient's own blood, which is then molded into a membrane and packed over the grafted bone to enhance bone density increase and improvement of the surrounding tissue.
Study summary
CGF membranes will be prepared using a swing-lock centrifuge. A full-thickness mucoperiosteal flap will be elevated in a narrow alveolar ridge. Implants will be inserted. Autologous bone chips will be harvested via bone scraping and used for augmentation, CGF membranes will be placed over the grafted area. Suturing of the mucoperiosteal flap. Radiographic evaluation of the bone density and tissue thickness will be performed by CBCT preoperatively, immediate postoperative and after the procedure by 4 months. Clinical evaluation of the tissue thickness using periodontal probe preoperatively, immediate postoperatively and after the procedure by 4 months
Eligibility
Primary outcome measure(s)
- tissue biotype — preoperative, immediate postoperative and 4 months after the procedure
using periodontal probe to measure gingival thickness
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cairo University | Giza | Cairo Governorate |
More Cairo University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07521514 on ClinicalTrials.gov ↗ ← All trials in Egypt